| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.42 | 3e-15 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.39 | 1e-12 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.28 | 3e-11 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.26 | 1e-09 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.35 | 8e-08 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.21 | 1e-07 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.23 | 1e-07 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.33 | 1e-06 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.31 | 1e-06 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.21 | 2e-06 |